| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $216K | +149.2% | +168.9% |
| R&D Expense | $721K | -8.9% | -31.1% |
| SG&A Expense | $553K | -15.1% | +12.2% |
| Operating Income | -$1.3M | +6.1% | +12.7% |
| Pre-tax Income | -$1.3M | +5.5% | +13.2% |
| Net Income | -$1.3M | +5.5% | +13.2% |
| EPS (Basic) | -$0.28 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.9M | -33.3% | +37.1% |
| Current Assets | $2.1M | -39.5% | -0.0% |
| Total Assets | $2.3M | -36.8% | +8.8% |
| Current Liabilities | $642K | -14.0% | -8.4% |
| Total Liabilities | $862K | -11.9% | +23.0% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.8M | — | — |
| Financing Cash Flow | $3.5M | — | — |
| +9.7% |
| +78.3% |
| EPS (Diluted) | -$0.28 | +9.7% | +78.3% |
| $1.5M |
| -45.7% |
| +2.0% |